 |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
||||
 |
 |
 |
 |
|
||||
 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Home > Health > Vaccine for genital herpes being tested at IUSMBy Mary Hardin | |
| Infectious disease researchers at the IU School of Medicine are conducting a clinical trial to determine the effectiveness of a vaccine to prevent genital herpes. Woman between the ages of 18 and 30 years who have not been infected with herpes simplex 1, which causes cold sores, or herpes simplex 2, also known as genital herpes, are eligible. Participants cannot be pregnant or breast feeding and be in generally good health.
Participants will be enrolled in the clinical trial for 20 months and must make eight to 10 visits to the IU Medical Center. Those enrolled in the study will be compensated for their time. For additional information or to enroll in the study, contact Sue Ford at 317-278-2945 or 1-888-557-5657.
| |
IU Home Pages
400 E. 7th Street. Bloomington, IN 47405
Phone: (812) 855-6494
Publication date: August 15, 2003
Comments: homepgs@indiana.edu
Copyright 2000, The
Trustees of Indiana University